Pharmaron Beijing Co Ltd Net Asset Quality Index
Pharmaron Beijing Co Ltd net asset quality index. Pharmaron Beijing Co Ltd (300759) has a Net Asset Quality Index of 58.8% as of September 2025. This metric measures the proportion of total assets financed by shareholders' equity — total assets of CN¥25.80 Billion minus total liabilities of CN¥10.62 Billion yields net assets of CN¥15.18 Billion. A higher index indicates a stronger, lower-leverage balance sheet. Check 300759 cash flow quality index to evaluate the quality of earnings relative to operating cash generation.
Quality Index
Net Assets
Total Assets
Total Liabilities
Net Asset Quality Index of Pharmaron Beijing Co Ltd (2014–2024)
Net asset quality index of Pharmaron Beijing Co Ltd from 2014 to 2024. This chart shows how Pharmaron Beijing Co Ltd's Net Asset Quality Index has evolved across 11 annual periods from 2014 to 2024. As of September 2025, the index stands at 58.8%, representing net assets of CN¥15.18 Billion against total assets of CN¥25.80 Billion CNY. See Pharmaron Beijing Co Ltd book value and equity for net asset value and shareholders' equity analysis.
Pharmaron Beijing Co Ltd Net Asset Quality Index by Year (2014–2024)
Pharmaron Beijing Co Ltd net asset quality index by year from 2014 to 2024. The table below presents the year-by-year Net Asset Quality Index for Pharmaron Beijing Co Ltd from 2014 to 2024, covering 11 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see 300759 market cap overview.
| Year | Quality Index | Net Assets (CNY) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2024 | 59.4% | CN¥14.22 Billion | CN¥23.93 Billion | CN¥9.70 Billion | ▲ +9.4 pp |
| 2023 | 50.0% | CN¥13.24 Billion | CN¥26.48 Billion | CN¥13.24 Billion | ▼ -2.9 pp |
| 2022 | 52.9% | CN¥10.84 Billion | CN¥20.49 Billion | CN¥9.65 Billion | ▼ -3.1 pp |
| 2021 | 56.0% | CN¥10.30 Billion | CN¥18.39 Billion | CN¥8.09 Billion | ▼ -19.0 pp |
| 2020 | 75.0% | CN¥8.93 Billion | CN¥11.91 Billion | CN¥2.98 Billion | ▼ -3.9 pp |
| 2019 | 78.9% | CN¥7.84 Billion | CN¥9.94 Billion | CN¥2.10 Billion | ▲ +28.3 pp |
| 2018 | 50.6% | CN¥2.34 Billion | CN¥4.63 Billion | CN¥2.28 Billion | ▼ -0.7 pp |
| 2017 | 51.3% | CN¥2.01 Billion | CN¥3.92 Billion | CN¥1.91 Billion | ▼ -11.6 pp |
| 2016 | 62.9% | CN¥1.76 Billion | CN¥2.80 Billion | CN¥1.04 Billion | ▲ +48.5 pp |
| 2015 | 14.3% | CN¥168.43 Million | CN¥1.17 Billion | CN¥1.01 Billion | ▼ -13.4 pp |
| 2014 | 27.7% | CN¥258.25 Million | CN¥931.46 Million | CN¥673.22 Million | — |